SPHERA FUNDS MANAGEMENT LTD. 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 5:28 pm Purchase | 2025-04-10 | 13G | Outlook Therapeutics, Inc. OTLK | SPHERA FUNDS MANAGEMENT LTD. | 2,571,426 7.490% | 857,142 (+50.00%) | Filing |
| 2025-03-03 3:58 pm Purchase | 2025-01-17 | 13G | Outlook Therapeutics, Inc. OTLK | SPHERA FUNDS MANAGEMENT LTD. | 1,714,284 5.210% | 1,714,284 (New Position) | Filing |